drugset / Trial / NCT03126721
The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults
Non-randomizedSingle-groupOpen-labelBasic science
Summary
This is a drug interaction study to evaluate the PF-06751979 at steady state on the pharmacokinetics of oral midazolam single doses in fixed sequences including single dose midazolam alone in period 1 followed by multiple doses of 100 mg PF-06751979 once a day for 11 days with single dose midazolam co-administered on Day 10 in period 2
Timeline
- Start
- 2017-04-18
- Primary completion
- 2017-07-11
- Completion
- 2017-07-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | 2 mg | Oral |
| Subject | PF-06751979 | Unknown | 100 mg | Oral |
Indications
No indication recorded.